The next board meeting for Aquestive Therapeutics Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 26th Annual Global Investor ConferenceSee details
Aquestive Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -26.8%, and profit growth estimate of -56.2% for FY25, based on top 9 analyst calls.